Trials / Terminated
TerminatedNCT04178616
Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective monocentric study of patients with systemic sclerosis disease. The primary outcome is to define the prevalence of olfactory disorders (hyposmia and anosmia) in systemic sclerosis disease. The secondary outcomes are: * To assess the correlation of olfaction disorders with clinical and biological and factors related to systemic sclerosis patients. * To estimate the frequency of sinonasal disorders in patients with systemic sclerosis disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | olfactory testing with specific odorants (localisation and identification) | Olfactory testing : ETOC (European Test of Olfactory capabilities) |
Timeline
- Start date
- 2019-12-31
- Primary completion
- 2020-03-13
- Completion
- 2020-03-13
- First posted
- 2019-11-26
- Last updated
- 2020-11-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04178616. Inclusion in this directory is not an endorsement.